Protein Kinase C Beta (PRKCB) is an integral component of signaling via the B-cell receptor in DLBCL, activating NF-κB and VEGF–mediated angiogenesis, and its tissue expression was shown to be an independent predictor of poor OS (68, 69). Here, NFKB1 is linked to diffuse large B-cell lymphoma.